UI Health Care says it is only one of very few sites to begin using SAINT therapy after the technology was licensed and further developed. "The key point with SAINT is that it is ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Experts highlight the potential of under-utilised treatments like monoamine oxidase inhibitors while examining emerging ...

The allegations concerning Elon Musk’s personal use of ketamine and other substances should be viewed with caution and ...

Studies show that eating oranges daily, regular exercise, and certain medications can lower depression risk by up to 40%, ...

Ketamine has promise as a potential treatment for bipolar depression, particularly for people whose condition hasn’t ...

Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a ...

Genetic predisposition to traits such as depressive affect, neuroticism and insomnia appeared significantly associated with ...

Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability ...

Ketamine is often viewed more as a party drug than a medicine. One Columbia clinic is using the drug to help patients with ...